Compare Nuscale Power Corporation (SMR) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuscale Power Corporation vs Tenet Healthcare Corporation — how do they compare? Nuscale Power Corporation trades at $7.43 (market cap $3.00B), while Tenet Healthcare Corporation trades at $260 (market cap $20.98B). The key difference: Tenet Healthcare Corporation is far larger — about 7× Nuscale Power Corporation's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, Nuscale Power Corporation nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nuscale Power Corporation for 29 Days and Tenet Healthcare Corporation for 15 Days on average.
| SMR | THC | |
|---|---|---|
Market Cap | $3.00B | $20.98B |
Volume | 43,143,109 | 428,008 |
Sector | Industrials | Health |
52-Week High | $53.43 | $280.77 |
52-Week Low | $7.32 | $161.37 |
Typical Hold Time | 29 Days | 15 Days |
Enterprise Value | $1.93B | $32.06B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NuScale Power (SMR) trades at $7.67, down 4.42% today, reflecting ongoing investor concerns about the company's financial performance. The stock shows bearish technical signals with negative moving averages and oscillators, while fundamentally the company faces significant challenges with a net income margin of -3,888.7% and negative cash flow from operations of $459.61 million in 2025. Recent news highlights both the nuclear industry's growth potential and specific challenges facing NuScale, including ongoing legal investigations.
Despite analyst consensus pointing to potential upside with a $11.25 price target, SMR faces substantial execution risks as it burns cash while pursuing commercialization. The company's ability to secure additional financing and achieve revenue growth will be critical for survival, making this a high-risk investment suitable only for investors comfortable with speculative nuclear technology plays.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with a bullish technical signal. The stock shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and robust profitability (ROE 53.31%, net margin 9.9%). Recent news highlights strong cash flow supporting capital returns and upcoming Q3 2026 results on October 29. Valuation appears reasonable with P/E of 10.07 and EV/EBITDA of 5.75.
THC presents a compelling investment case with strong analyst support (81% buy ratings) and 7% upside to consensus target of $283.36. Key catalysts include sustained earnings momentum and efficient capital allocation. Risks include surgical volume pressures and cash flow sustainability concerns amid aggressive buybacks. The stock's current technical setup near pivot point $259 suggests balanced risk-reward.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuscale Power Corporation
NuScale Power Corporation is a leading developer of Small Modular Reactor (SMR) technology. The company's flagship product is a light water reactor SMR designed to generate clean, reliable, and scalable nuclear power. NuScale's technology is poised to address the global demand for carbon-free energy by offering a safer, smaller, and more flexible alternative to traditional large-scale nuclear power plants, with applications in electricity generation, desalination, and process heat.
Read more on SMR →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
